Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.7400
-0.0300 (-3.90%)
Mar 12, 2026, 3:59 PM EST
Vaxart Market Cap
Vaxart has a market cap or net worth of $176.97 million as of March 13, 2026. Its market cap has increased by 48.72% in one year.
Market Cap
176.97M
Enterprise Value
126.21M
Revenue
237.26M
Ranking
n/a
PE Ratio
10.53
Stock Price
$0.74
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 176.97M, an increase of 193.24%. That is a compound annual growth rate of 14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 176.97M | 112.88% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 366.34M |
| CytoDyn | 298.03M |
| Silence Therapeutics | 296.16M |
| BioStem Technologies | 84.89M |
| HST Global | 70.72M |
| Nuo Therapeutics | 62.29M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 47.84M |